Personal information
Biography
Mark Isalan carried out a Ph.D. in engineering zinc fingers to bind new DNA sequences at the MRC LMB, in the University of Cambridge UK,1996-2000. This work was supervised by Prof. Sir Aaron Klug, OM, FRS, and continued postdoctorally from 2000-2002 at Gendaq Ltd, UK (now owned by Sangamo Biosciences, Richmond CA). The work ultimately contributed to the CompoZr zinc finger nucleases now available commercially from Sigma Aldrich. From 2002-2006 Dr. Isalan was awarded a Wellcome Trust International Research Fellowship to carry out research on engineering artificial gene networks in Prof. Luis Serrano's group at the EMBL Heidelberg, Germany. From 2006-2013 he was a group leader at the EMBL-CRG Systems Biology Unit in Barcelona, specialising in synthetic gene network engineering. He moved to Imperial College London in 2013, where he is Professor of Synthetic Biology. He continues to work in protein and gene network engineering, aiming to design biological systems that behave predictably and robustly.
Activities
Employment (5)
Education and qualifications (2)
Professional activities (2)
Funding (15)
N629092312099
108908/B/15/Z
102944/Z/13/Z
066543/B/01/Z
066543/D/01/Z
066543/C/01/Z
Works (50 of 81)
E-MTAB-3233
10.1002/9780470015902.a0020899.pub2
9780470015902